devender_naik
☆    

Hyderabad,
2006-04-27 10:12

Posting: # 90
Views: 4,916
 

 restriction [Regulatives / Guidelines]

Why is the subject allowed to be in sitting position only for a period of about 2hours post dose? (As per FDA).

dd
H_Rotter
★    

Germany,
2006-04-27 11:48

@ devender_naik
Posting: # 91
Views: 3,854
 

 posture

» Why is the subject allowed to be in sitting position only for a period of about 2hours post dose? (As per FDA).

Hi Devender,

which (FDA) guideline are you referring to?

Of course posture should be standardized in order to minimize variability, but where does sitting for 2 h post dose come from?

Best regards,
Hermann
chintan98
●    

2006-07-11 07:43

@ devender_naik
Posting: # 162
Views: 3,972
 

 restriction

Hi

I guess posture restriction is all about depends on nature of drug. Ideally we use to keep two hours post dose but it is not mentioned in any guideline.

Regards,

Chintan Mehta
Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
19,567 posts in 4,150 threads, 1,341 registered users;
online 9 (0 registered, 9 guests [including 5 identified bots]).
Forum time (Europe/Vienna): 11:05 CEST

Power. That which statisticians are always calculating
but never have.    Stephen Senn

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5